|
|
||||||||
1 Department of Molecular Physiology and Biophysics, University of Vermont College of Medicine, Burlington, Vermont 05405; and 2 Molecular Cardiovascular Biology, Children's Hospital, Cincinnati, Ohio 45229
Two
myosin isoforms are expressed in myocardium, 
-homodimers
(V1) and 
-homodimers (V3). V1
exhibits higher velocities and myofibrillar ATPase activities compared
with V3. We also observed this for cardiac myosin from
normal (V1) and propylthiouracil-treated (V3)
mice. Actin velocity in a motility assay
(Vactin) over V1 myosin was twice
that of V3 as was the myofibrillar ATPase. Myosin's average force (Favg) was similar for V1 and
V3. Comparing Vactin and
Favg across species for both V1 and
V3, our laboratory showed previously (VanBuren P, Harris
DE, Alpert NR, and Warshaw DM. Circ Res 77: 439-444,
1995) that mouse V1 has greater
Vactin and Favg compared with rabbit
V1. Mouse V3 Vactin was
twice that of rabbit Vactin. To understand
myosin's molecular structure and function, we compared
- and
-cardiac myosin sequences from rodents and rabbits. The rabbit
-
and
-cardiac myosin differed by eight and four amino acids,
respectively, compared with rodents. These residues are localized to
both the motor domain and the rod. These differences in sequence and
mechanical performance may be an evolutionary attempt to match a
myosin's mechanical behavior to the heart's power requirements.
contractile proteins; heart; motility assay; molecular motor
This article has been cited by other articles:
![]() |
C.-K. Du, S. Morimoto, K. Nishii, R. Minakami, M. Ohta, N. Tadano, Q.-W. Lu, Y.-Y. Wang, D.-Y. Zhan, M. Mochizuki, et al. Knock-In Mouse Model of Dilated Cardiomyopathy Caused by Troponin Mutation Circ. Res., July 20, 2007; 101(2): 185 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schoffstall, N. M. Brunet, S. Williams, V. F. Miller, A. T. Barnes, F. Wang, L. A. Compton, L. A. McFadden, D. W. Taylor, M. Seavy, et al. Ca2+ sensitivity of regulated cardiac thin filament sliding does not depend on myosin isoform J. Physiol., December 15, 2006; 577(3): 935 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Korte, T. J. Herron, M. J. Rovetto, and K. S. McDonald Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H801 - H812. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Alpert, S. A. Mohiddin, D. Tripodi, J. Jacobson-Hatzell, K. Vaughn-Whitley, C. Brosseau, D. M. Warshaw, and L. Fananapazir Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1097 - H1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Davis, J. B Pillai, M. Gupta, and M. P. Gupta Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of {alpha}-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1477 - H1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krenz, A. Sanbe, F. Bouyer-Dalloz, J. Gulick, R. Klevitsky, T. E. Hewett, H. E. Osinska, J. N. Lorenz, C. Brosseau, A. Federico, et al. Analysis of Myosin Heavy Chain Functionality in the Heart J. Biol. Chem., May 2, 2003; 278(19): 17466 - 17474. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |